All Posts Archives - Page 2 of 9 - EverGlade Consulting

All Posts

EverGlade Consulting

Unlocking Federal Opportunities for AI & Technology Innovators

Leave a Comment / AI, All Posts, Emerging Technologies / By

Securing federal funding is more than a financial boost – it’s a strategic move that positions your company as a leader in innovation. EverGlade Consulting’s proven process helps small and medium-sized AI and tech firms navigate complex federal funding landscapes. Our process works because we focus on your business goals, not just technical details, ensuring […]

Unlocking Federal Opportunities for AI & Technology Innovators Read More »

Leveraging AI to Enhance Business Intelligence

Leveraging AI to Enhance Business Intelligence

Leave a Comment / All Posts, DIU, Emerging Technologies / By

DOD’s New Initiative_AOI Solicitation Leveraging AI to Enhance Business Intelligence: The DoD’s New Initiative The Department of Defense (DoD) has identified a critical need to modernize business intelligence assessments to keep pace with evolving challenges in due diligence evaluations and industrial foreign influence analyses. To address this, the Defense Innovation Unit (DIU) has released an

Leveraging AI to Enhance Business Intelligence Read More »

ARPA-H_EIH health and biomedical research

Emerging Health Innovators (EHI) Initiative

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA_H_SOL_25_118_EHI_Solicitation (1) Emerging Health Innovators Solicitation: An Opportunity to Revolutionize Health Innovation The Advanced Research Projects Agency for Health (ARPA-H) has issued the Emerging Health Innovators (EHI) Initiative Solicitation (ARPA-H-SOL-25-118), a groundbreaking funding opportunity aimed at empowering both early-career researchers and community innovators to advance health and biomedical research. Through the EHI Initiative, ARPA-H seeks

Emerging Health Innovators (EHI) Initiative Read More »

MTEC RPP medical techniques, knowledge products, and materials

EverGlade Consulting Funding Alert: MTEC Fiscal Year 2025 Multi-Topic Request for Project Proposals

Leave a Comment / All Posts, Life Sciences, MTEC / By

MTEC-25-04-MultiTopic-RPP_Final Overview of the Solicitation The Medical Technology Enterprise Consortium (MTEC) has recently announced its Fiscal Year 2025 Multi-Topic Request for Project Proposals (RPP). This RPP focuses on eleven key Focus Areas to stimulate innovative medical prototype, technological, and knowledge solutions with military relevance. The RPP targets the following focus areas: Focus Area 1 –

EverGlade Consulting Funding Alert: MTEC Fiscal Year 2025 Multi-Topic Request for Project Proposals Read More »

ARPA-H, RAPID Funding Alert

EverGlade Consulting Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RAPID_Special_Notice ARPA-H’s RAPID Program The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). This initiative aims to revolutionize the prolonged diagnostic odyssey faced by millions of rare disease patients worldwide. Utilizing fragmented datasets and state-of-the-art technologies, RAPID aims to democratize access

EverGlade Consulting Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Read More »

ARPA-H PROSPR prolonging resilience

EverGlade Consulting Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA-H-SOL-25-125_Special_Notice ARPA-H’s PROSPR Program The Advanced Research Projects Agency for Health (ARPA-H) has announced the PROactive Solutions for Prolonging Resilience (PROSPR) initiative, an ambitious program designed to extend the healthspan of Americans by addressing the underlying causes of age-related health loss. By pioneering innovative interventions that target age-induced health deterioration, ARPA-H aims to revolutionize healthcare

EverGlade Consulting Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR) Read More »

PAHPA program funding

After the CR: Funding Opportunities and Gaps in Pandemic Preparedness

Leave a Comment / All Posts, BARDA, Life Sciences / By

Congress’s passage of a continuing resolution (CR) has averted a shutdown and provided temporary relief until late March. However, this short-term fix exposes significant gaps in public health and technology preparedness that demand immediate attention. As critical programs approach expiration and threats beyond the Pandemic and All-Hazards Preparedness Act (PAHPA) remain unresolved, lawmakers have a

After the CR: Funding Opportunities and Gaps in Pandemic Preparedness Read More »

Targeting Cancer Cells

EverGlade Consulting Helps SonALAsense Secure up to $46 Million in ARPA-H Funding

Leave a Comment / All Posts / By

EverGlade Consulting, a national consulting firm, has helped SonALAsense successfully secure up to $46 million in funding to develop a minimally or non-invasive ultrasound treatment to activate a compound that can destroy cancer cells. Improving Patient Outcomes The $46 million in ARPA-H funding, announced as part of ARPA-H’s initiative to revolutionize cancer treatment through cutting-edge

EverGlade Consulting Helps SonALAsense Secure up to $46 Million in ARPA-H Funding Read More »

Radiation & Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices

Leave a Comment / All Posts, Life Sciences, NIAID / By

NIAID_Presolicitation_Notice_Rad_Nuc MCMs Overview of Solicitation The National Institute of Allergy and Infectious Diseases (NIAID), under the National Institutes of Health (NIH), has released a pre-solicitation notice for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices. This Broad Agency Announcement (BAA 75N93024R00020) is an invitation for innovators in the critical field of radiation emergency

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices Read More »

ACTR Initiative clinical trials

Transforming Clinical Trials with the Advancing Clinical Trial Readiness (ACTR) Initiative

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA-H launches groundbreaking funding opportunity The Advancing Clinical Trial Readiness (ACTR) Initiative, spearheaded by ARPA-H’s Resilient Systems Office (RSO), aims to revolutionize clinical trials by developing a decentralized, efficient, and accessible infrastructure. Overview of Solicitation The ACTR Initiative is focused on creating tools, networks, and infrastructure to enable decentralized and on-demand clinical trials. By integrating

Transforming Clinical Trials with the Advancing Clinical Trial Readiness (ACTR) Initiative Read More »

ARPA-H health equity, technology, and biomedical research

Emerging Health Innovators (EHI) Initiative Proposer’s Day

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA-H-SN-25-119 (1) The Advanced Research Projects Agency for Health (ARPA-H) has launched the Emerging Health Innovators (EHI) Initiative, a transformative funding opportunity aimed at empowering early-career researchers and community-based innovators to revolutionize healthcare. To support this initiative, ARPA-H is holding a virtual Proposer’s Day on January 8th, 2025, from 11AM to 4PM EDT. Overview of

Emerging Health Innovators (EHI) Initiative Proposer’s Day Read More »

medical countermeasures for biodefense and infectious diseases

Omnibus Solicitation Seeks Medical Countermeasures for Biodefense and Emerging Infectious Disease

Leave a Comment / All Posts, Life Sciences, NIAID / By

HHS-NIH-NIAID-BAA2025-1 The U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID), has released the Broad Agency Announcement (BAA) HHS-NIH-NIAID-BAA2025-1. This announcement presents an exciting opportunity for researchers, organizations, and industry leaders to contribute to critical biomedical and biodefense initiatives.

Omnibus Solicitation Seeks Medical Countermeasures for Biodefense and Emerging Infectious Disease Read More »

Scroll to Top